Abstract:We report for the first time that the protective effect of β‐hydroxybutyrate (BHB) against stroke and glucose deprivation is enantiomer selective. We discovered that D‐BHB treatment prevented the cleavage of the lysosomal membrane protein LAMP2, maintained lysosome integrity and stimulated the autophagic flux. Also, D‐BHB notably reduced the activation of the PERK and IRE1α branches of the unfolded protein response (UPR), attenuating protein synthesis inhibition and preventing endoplasmic reticulum stress. Together our results support the therapeutic use of D‐BHB treatment post‐ischemia, by preventing the loss of proteostasis through maintaining lysosome integrity, allowing functional autophagy, and attenuating UPR activation. Ischemic stroke is a leading cause of disability worldwide. There is no simple treatment to alleviate ischemic brain injury, as thrombolytic therapy is applicable within a narrow time window. During the last years, the ketogenic diet (KD) and the exogenous administration of the ketone body β‐hydroxybutyrate (BHB) have been proposed as therapeutic tools for acute neurological disorders and both can reduce ischemic brain injury. However, the mechanisms involved are not completely clear. We have previously shown that the D enantiomer of BHB stimulates the autophagic flux in cultured neurons exposed to glucose deprivation (GD) and in the brain of hypoglycemic rats. Here, we have investigated the effect of the systemic administration of D‐BHB, followed by its continuous infusion after middle cerebral artery occlusion (MCAO), on the autophagy‐lysosomal pathway and the activation of the unfolded protein response (UPR). Results show for the first time that the protective effect of BHB against MCAO injury is enantiomer selective as only D‐BHB, the physiologic enantiomer of BHB, significantly reduced brain injury. D‐BHB treatment prevented the cleavage of the lysosomal membrane protein LAMP2 and stimulated the autophagic flux in the ischemic core and the penumbra. In addition, D‐BHB notably reduced the activation of the PERK/eIF2α/ATF4 pathway of the UPR and inhibited IRE1α phosphorylation. L‐BHB showed no significant effect relative to ischemic animals. In cortical cultures under GD, D‐BHB prevented LAMP2 cleavage and decreased lysosomal number. It also abated the activation of the PERK/eIF2α/ATF4 pathway, partially sustained protein synthesis, and reduced pIRE1α. In contrast, L‐BHB showed no significant effects. Results suggest that protection elicited by D‐BHB treatment post‐ischemia prevents lysosomal rupture allowing functional autophagy, preventing the loss of proteostasis and UPR activation.

Ketogenic β‐hydroxybutyrate regulates β‐hydroxybutyrylation of TCA cycle‐associated enzymes and attenuates disease‐associated pathologies in Alzheimer's mice

BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies

Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer’s mouse model and stimulates synaptic plasticity pathway enzymes

Ketogenic Diet Alleviates Cognitive Dysfunction and Neuroinflammation in APP/PS1 Mice Via the Nrf2/HO-1 and NF-κB Signaling Pathways

A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease

Ketogenic diet: a nutritional protocol for a non-pharmacological treatment of Alzheimer’s disease

Ketogenic diet reshapes cancer metabolism through lysine β-hydroxybutyrylation

A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis

Ketogenic Diet Ameliorates Cognitive Impairment and Neuroinflammation in a Mouse Model of Alzheimer’s Disease

β-Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2/AMPK/PINK1/Parkin pathway

Modulation of the autophagy‐lysosomal pathway and endoplasmic reticulum stress by ketone bodies in experimental models of stroke

Effect of the Ketone Body, D-β-Hydroxybutyrate, on Sirtuin2-Mediated Regulation of Mitochondrial Quality Control and the Autophagy–Lysosomal Pathway

β-hydroxybutyrate and its metabolic effects on age-associated pathology

Ketogenic interventions restore cognition and modulate peripheral metabolic dysfunctions in Alzheimer’s disease mouse models

Early Interleukin-6 Enhances Hepatic Ketogenesis in APPSWE/PSEN1dE9 Mice Via 3-Hydroxy-3-methylglutary-coa Synthase 2 Signaling Activation by P38/nuclear Factor Κb P65

BETA-HYDROXYBUTYRATE COUNTERACTS THE DELETERIOUS EFFECTS OF A SATURATED HIGH-FAT DIET ON SYNAPTIC AMPA RECEPTORS AND COGNITIVE PERFORMANCE

Differences in the Effect of Beta-Hydroxybutyrate on the Mitochondrial Biogenesis, Oxidative Stress and Inflammation Markers in Tissues from Young and Old Rats